Drugs / ssCART-19 Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04825496 | Apr 2021 → Dec 2023 | acute lymphoblastic leukemia | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ssCART-19 Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04825496 ↗ |
| Route | Intravenous | “Route of administration: Intravenous injection.” NCT04825496 ↗ |